Anti-Infective Drugs Advisory Committee Meeting; Notice of Meeting; Cancellation, 18483 [07-1825]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 70 / Thursday, April 12, 2007 / Notices
Surveillance to Determine the
Prevalence of the Autism Spectrum
Disorders and Other Developmental
Disabilities in Early Childhood
Populations,’’ RFA DD 07–007.
For Further Information Contact:
Sheree Williams, PhD, Scientific Review
Administrator, Office of the Chief
Science Officer, CDC, 1600 Clifton Road
NE., Mailstop D 72, Atlanta, GA 30333,
Telephone 404–639–4896.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 5, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6927 Filed 4–11–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Anti-Infective Drugs Advisory
Committee Meeting; Notice of Meeting;
Cancellation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
rmajette on PROD1PC67 with NOTICES
SUMMARY: The meeting of the AntiInfective Drugs Advisory Committee
scheduled for April 11, 2007, is
cancelled. This meeting was announced
in the Federal Register of March 16,
2007 (72 FR 12620).
FOR FURTHER INFORMATION CONTACT: Lt.
Sohail Mosaddegh, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630
Fishers Lane, rm. 1093), Rockville, MD
20857, 301–827–7001, FAX: 301–827–
6776, e-mail:
sohail.mosaddegh@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (443–0572 in the
Washington, DC area), code
3014512530. Please call the Information
Line for up-to-date information on this
meeting.
Dated: April 8, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. 07–1825 Filed 4–9–07; 3:14 pm]
BILLING CODE 4160–01–S
VerDate Aug<31>2005
15:49 Apr 11, 2007
Jkt 211001
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2007–27793]
Collection of Information Under
Review by Office of Management and
Budget: OMB Control Numbers 1625–
0002, 1625–0017, 1625–0030, 1625–
0072, and 1625–0078
Coast Guard, DHS.
Request for comments.
AGENCY:
ACTION:
SUMMARY: In compliance with the
Paperwork Reduction Act of 1995, the
U.S. Coast Guard intends to submit
Information Collection Requests (ICRs)
to the Office of Management and Budget
(OMB) requesting an extension of their
approval for the following collections of
information: (1) 1625–0002, Application
for Vessel Inspection, Waiver, and
Continuous Synopsis Record; (2) 1625–
0017, Various International Agreement
Safety Certificates and Documents; (3)
1625–0030, Oil and Hazardous
Materials Transfer Procedures; (4) 1625–
0072, Waste Management Plans, Refuse
Discharge Logs, and Letters of
Instruction for Certain Persons-inCharge (PIC); and (5) 1625–0078,
Licensing and Manning Requirements
for Officers on Towing Vessels. Before
submitting these ICRs to OMB, the Coast
Guard is inviting comments as
described below.
DATES: Comments must reach the Coast
Guard on or before June 11, 2007.
ADDRESSES: To make sure your
comments and related material do not
enter the docket [USCG–2007–27793]
more than once, please submit them by
only one of the following means:
(1) By mail to the Docket Management
Facility, U.S. Department of
Transportation (DOT), room PL–401,
400 Seventh Street, SW., Washington,
DC 20590–0001.
(2) By delivery to room PL–401 on the
Plaza level of the Nassif Building, 400
Seventh Street, SW., Washington, DC,
between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
The telephone number is 202–366–
9329.
(3) By fax to the Docket Management
Facility at 202–493–2251.
(4) Electronically through the Web
Site for the Docket Management System
at https://dms.dot.gov.
The Docket Management Facility
maintains the public docket for this
notice. Comments and material received
from the public, as well as documents
mentioned in this notice as being
available in the docket, will become part
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
18483
of this docket and will be available for
inspection or copying at room PL–401
on the Plaza level of the Nassif Building,
400 Seventh Street, SW., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
You may also find this docket on the
Internet at https://dms.dot.gov.
Copies of complete ICRs are available
through this docket on the Internet at
https://dms.dot.gov, and also from
Commandant (CG–611), U.S. Coast
Guard Headquarters, room 10–1236
(Attn: Mr. Arthur Requina), 2100 2nd
Street, SW., Washington, DC 20593–
0001. The telephone number is 202–
475–3523.
FOR FURTHER INFORMATION CONTACT: Mr.
Arthur Requina, Office of Information
Management, telephone 202–475–3523,
or fax 202–475–3929, for questions on
these documents; or telephone Ms.
Renee V. Wright, Program Manager,
Docket Operations, 202–493–0402, for
questions on the docket.
SUPPLEMENTARY INFORMATION:
Public Participation and Request for
Comments
We encourage you to respond to this
request by submitting comments and
related materials. We will post all
comments received, without change, to
https://dms.dot.gov; they will include
any personal information you provided.
We have an agreement with DOT to use
the Docket Management Facility. Please
see the paragraph on DOT’s ‘‘Privacy
Act Policy’’ below.
Submitting comments: If you submit a
comment, please include your name and
address, identify the docket number
[USCG–2007–27793], indicate the
specific section of the document to
which each comment applies, providing
a reason for each comment. You may
submit your comments and material by
electronic means, mail, fax, or delivery
to the Docket Management Facility at
the address under ADDRESSES; but
please submit them by only one means.
If you submit them by mail or delivery,
submit them in an unbound format, no
larger than 81⁄2 by 11 inches, suitable for
copying and electronic filing. If you
submit them by mail and would like to
know that they reached the Facility,
please enclose a stamped, self-addressed
postcard or envelope. We will consider
all comments and material received
during the comment period. We may
change the documents supporting this
collection of information or even the
underlying requirements in view of
them.
Viewing comments and documents:
To view comments, as well as
documents mentioned in this notice as
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 72, Number 70 (Thursday, April 12, 2007)]
[Notices]
[Page 18483]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1825]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Anti-Infective Drugs Advisory Committee Meeting; Notice of
Meeting; Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The meeting of the Anti-Infective Drugs Advisory Committee
scheduled for April 11, 2007, is cancelled. This meeting was announced
in the Federal Register of March 16, 2007 (72 FR 12620).
FOR FURTHER INFORMATION CONTACT: Lt. Sohail Mosaddegh, Center for Drug
Evaluation and Research (HFD-21), Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093),
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail:
sohail.mosaddegh@fda.hhs.gov, or FDA Advisory Committee Information
Line, 1-800-741-8138 (443-0572 in the Washington, DC area), code
3014512530. Please call the Information Line for up-to-date information
on this meeting.
Dated: April 8, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. 07-1825 Filed 4-9-07; 3:14 pm]
BILLING CODE 4160-01-S
